Komuta, M.

patient incph portal didanosine hypertension liver diagnosis stavudine portal hypertension hiv-infected patients exposure study control noncirrhotic incph diagnosis treatment hiv-associated hiv-associated incph hiv-infected idiopathic control patients disorder platelet count noncirrhotic portal hypertension follow-up combination <0.001 antiretroviral mitochondrial hiv infection incph patients month disease count tenofovir liver disease number platelet cirrhosis biopsy liver failure pharmacol incph cases duration association risk factors prevalence infection netherland publishing range result aliment blackwell survival ratio population antiretroviral drugs 875-885 antiretroviral treatment characteristic report fi brosis model feature hiv treatment centres obliterative portal venopathy schouten brosi ficiency table factor liver test disturbances case –control study signi analysis identi fied outcome regenerative hyperplasia hiv diagnosis